Clinical Trials Browser

Breast Neoplasms × Alpelisib × 30 days × Clear all

NCT05038735 2026-06-02

EPIK-B5

Phase 3 Active not recruiting

Breast Neoplasms

NCT05392608 2026-05-22

SEQUEL-Breast

Phase 2 Active not recruiting

Breast Neoplasms, Genetic Diseases, Inborn